Charalampos S. Floudas
Charalampos S. Floudas
National Cancer Insitute
Verified email at - Homepage
Cited by
Cited by
Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy
V Kumar, N Chaudhary, M Garg, CS Floudas, P Soni, AB Chandra
Frontiers in pharmacology 8, 49, 2017
Tremelimumab in Combination With Microwave Ablation in Patients With Refractory Biliary Tract Cancer
C Xie, AG Duffy, D Mabry‐Hrones, B Wood, E Levy, V Krishnasamy, ...
Hepatology 69 (5), 2048-2060, 2019
Corrigendum: Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy
V Kumar, N Chaudhary, M Garg, CS Floudas, P Soni, AB Chandra
Frontiers in pharmacology 8, 311, 2017
Combined immune checkpoint inhibition (ICI) with tremelimumab and durvalumab in patients with advanced hepatocellular carcinoma (HCC) or biliary tract carcinomas (BTC).
CS Floudas, C Xie, G Brar, MP Morelli, S Fioravanti, M Walker, ...
Journal of Clinical Oncology 37 (4_suppl), 336-336, 2019
A Pilot Study of the PD-1 Targeting Agent AMP-224 Used With Low-Dose Cyclophosphamide and Stereotactic Body Radiation Therapy in Patients With Metastatic Colorectal Cancer
CS Floudas, G Brar, D Mabry-Hrones, AG Duffy, B Wood, E Levy, ...
Clinical colorectal cancer 18 (4), e349-e360, 2019
Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)
M Bilusic, S McMahon, RA Madan, F Karzai, YT Tsai, RN Donahue, ...
Journal for Immunotherapy of Cancer 9 (3), 2021
Immunotherapy: current status and future perspectives
CS Floudas, G Brar, TF Greten
Digestive Diseases and Sciences 64, 1030-1040, 2019
Vemurafenib in leptomeningeal carcinomatosis from melanoma: a case report of near-complete response and prolonged survival
CS Floudas, AB Chandra, Y Xu
Melanoma research 26 (3), 312-315, 2016
Kikuchi’s lymphadenopathy: a relatively rare but important cause of lymphadenopathy in Greece, potentially associated with the antiphospholipid syndrome
TP Vassilakopoulos, GA Pangalis, MP Siakantaris, G Levidou, ...
Rheumatology international 30, 925-932, 2010
Identifying genetic interactions associated with late-onset Alzheimer’s disease
CS Floudas, N Um, MI Kamboh, MM Barmada, S Visweswaran
BioData mining 7 (1), 1-19, 2014
Loss of vision associated with angioid streaks in β-thalassemia intermedia
A Aessopos, CS Floudas, M Kati, M Tsironi, X Giakoumi, C Livir-Rallatos, ...
International journal of hematology 87, 35-38, 2008
Rheumatoid arthritis in thalassemia intermedia: coincidence or association?
X Giakoumi, M Tsironi, C Floudas, E Polymeropoylos, E Papalambros, ...
The Israel Medical Association Journal: IMAJ 7 (10), 667-669, 2005
Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer
PJ DeMaria, K Lee-Wisdom, RN Donahue, RA Madan, F Karzai, ...
Journal for Immunotherapy of Cancer 9 (9), 2021
Obscure gastrointestinal bleeding and calcific aortic stenosis (Heyde's syndrome)
CS Floudas, I Moyssakis, P Pappas, EJ Gialafos, A Aessopos
International journal of cardiology 127 (2), 292-294, 2008
Impaired aortic elastic properties in patients with systemic sarcoidosis
I Moyssakis, E Gialafos, N Tentolouris, CS Floudas, TG Papaioannou, ...
European journal of clinical investigation 38 (2), 82-89, 2008
The contemporary management of cancers of the sinonasal tract in adults
R Thawani, MS Kim, A Arastu, Z Feng, MT West, NF Taflin, KZ Thein, R Li, ...
CA: A Cancer Journal for Clinicians 73 (1), 72-112, 2023
Phase II evaluation of the triple combination of PDS0101, M9241, and bintrafusp alfa in patients with HPV 16 positive malignancies
J Strauss, CS Floudas, HA Sater, M Manu, E Lamping, DC Francis, ...
J. Clin. Oncol 39 (2501), 10.1200, 2021
Nodular lung calcifications following varicella zoster virus pneumonia
CS Floudas, MA Kanakis, A Andreopoulos, GA Vaiopoulos
QJM: An International Journal of Medicine 101 (2), 159-159, 2008
Hepatocellular carcinoma (HCC) survival by etiology: A SEER-Medicare database analysis.
G Brar, T McNeel, K McGlynn, B Graubard, CS Floudas, MP Morelli, C Xie, ...
Journal of Clinical Oncology 37 (4_suppl), 201-201, 2019
A phase I/II study of pexa-vec oncolytic virus in combination with immune checkpoint inhibition in refractory colorectal cancer: Safety report.
MP Morelli, C Xie, G Brar, CS Floudas, S Fioravanti, M Walker, ...
Journal of Clinical Oncology 37 (4_suppl), 646-646, 2019
The system can't perform the operation now. Try again later.
Articles 1–20